426 - 450 of 8399 Results
Title
Year
-
OPENTitle: SynBot is an open-source image analysis software for automated quantification of synapsesJournal Name: Cell Reports MethodsPublisher: Elsevier BVVol: 4Issue #: 9Start Page: 100861End Page: 100861Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.crmeth.2024.100861Best OA location URL: https://doi.org/10.1016/j.crmeth.2024.100861Citation Count: 8
-
OPENTitle: An Inducible Luminescent System to Explore Parkinson’s Disease-Associated GenesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 25Issue #: 17Start Page: 9493End Page: 9493Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms25179493Best OA location URL: https://doi.org/10.3390/ijms25179493Citation Count: 0
- ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer’s disease through BDNF/NGFR signaling2024OPENTitle: ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer’s disease through BDNF/NGFR signalingJournal Name: Cell GenomicsPublisher: Elsevier BVVol: 4Issue #: 9Start Page: 100642End Page: 100642Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xgen.2024.100642Best OA location URL: https://pub.dzne.de/record/272136/files/DZNE-2024-01131.pdfCitation Count: 4
- Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populations2024OPENTitle: Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populationsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 10Start Page: 7174End Page: 7192Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14208Best OA location URL: https://doi.org/10.1002/alz.14208Citation Count: 5
-
RESTRICTEDTitle: Inflammation and heterogeneity in synucleinopathiesJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3389/fimmu.2024.1432342Citation Count: 0
- Shared and distinct cortical morphometric alterations in five neuropsychiatric symptoms of Parkinson’s disease2024OPENTitle: Shared and distinct cortical morphometric alterations in five neuropsychiatric symptoms of Parkinson’s diseaseJournal Name: Translational PsychiatryPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41398-024-03070-zBest OA location URL: https://doi.org/10.1038/s41398-024-03070-zCitation Count: 2
- Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM502024OPENTitle: Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM50Journal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.99914Best OA location URL: https://cdn.elifesciences.org/articles/99914/elife-99914-v1.pdfCitation Count: 2
- Medication improves velocity, reaction time, and movement time but not amplitude or error during memory‐guided reaching in Parkinson's disease2024OPENTitle: Medication improves velocity, reaction time, and movement time but not amplitude or error during memory‐guided reaching in Parkinson's diseaseJournal Name: Physiological ReportsPublisher: WileyVol: 12Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14814/phy2.16150Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.14814/phy2.16150Citation Count: 0
- Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson’s disease, results from a phase II randomised controlled trial2024OPENTitle: Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson’s disease, results from a phase II randomised controlled trialJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 8Start Page: e0309217End Page: e0309217Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0309217Citation Count: 0
-
OPENTitle: Blood‐based multivariate methylation risk score for cognitive impairment and dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14061Best OA location URL: https://doi.org/10.1002/alz.14061Citation Count: 6
- Single-Molecule Fingerprinting Reveals Different Growth Mechanisms in Seed Amplification Assays for Different Polymorphs of α-Synuclein Fibrils2024OPENTitle: Single-Molecule Fingerprinting Reveals Different Growth Mechanisms in Seed Amplification Assays for Different Polymorphs of α-Synuclein FibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 18Start Page: 3270End Page: 3285Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00185Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.4c00185?ref=article_openPDFCitation Count: 1
-
RESTRICTEDTitle: Synthesis at the Interface of Chemistry and BiologyJournal Name: Accounts of Chemical ResearchPublisher: American Chemical Society (ACS)Vol: 57Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.accounts.4c00320Citation Count: 0
-
RESTRICTEDTitle: Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson’s diseaseJournal Name: NeuroradiologyPublisher: Springer Science and Business Media LLCVol: 66Issue #: 11Start Page: 1955End Page: 1966Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00234-024-03452-6Citation Count: 1
- Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PD2024OPENTitle: Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PDJournal Name: Frontiers in Digital HealthPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fdgth.2024.1435693Best OA location URL: https://doi.org/10.3389/fdgth.2024.1435693Citation Count: 2
- Cell-specific expression of key mitochondrial enzymes limits OXPHOS in astrocytes of the adult human neocortex and hippocampal formation2024OPENTitle: Cell-specific expression of key mitochondrial enzymes limits OXPHOS in astrocytes of the adult human neocortex and hippocampal formationJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s42003-024-06751-zBest OA location URL: https://www.nature.com/articles/s42003-024-06751-z.pdfCitation Count: 6
- Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification Trials2024OPENTitle: Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification TrialsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 11Start Page: 1345End Page: 1354Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.14191Best OA location URL: https://doi.org/10.1002/mdc3.14191Citation Count: 0
-
OPENTitle: IAPP - oligomerisation levels in plasma of people with type 2 diabetesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-70255-3Citation Count: 0
- Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers2024OPENTitle: Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00763-6Citation Count: 7
- Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies2024OPENTitle: Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologiesJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 385Issue #: 6711Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abm6131Best OA location URL: https://doi.org/10.1101/2024.06.23.598940Citation Count: 21
- Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits2024OPENTitle: Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficitsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 34Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adn6016Best OA location URL: https://doi.org/10.1126/sciadv.adn6016Citation Count: 8
-
OPENTitle: MRI subtypes in Parkinson’s disease across diverse populations and clustering approachesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00759-2Best OA location URL: https://doi.org/10.1038/s41531-024-00759-2Citation Count: 4
- Sleep duration in middle-aged years of life predicts the age of diagnosis of Parkinson's disease2024OPENTitle: Sleep duration in middle-aged years of life predicts the age of diagnosis of Parkinson's diseaseJournal Name: Sleep Medicine: XPublisher: Elsevier BVVol: 8Issue #:Start Page: 100123End Page: 100123Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.sleepx.2024.100123Citation Count: 1
- Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy2024OPENTitle: Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsyJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-024-00747-3Best OA location URL: https://doi.org/10.1186/s13024-024-00747-3Citation Count: 9
-
OPENTitle: Loss-of-function variants in ITSN1 confer high risk of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00752-9Best OA location URL: https://doi.org/10.1038/s41531-024-00752-9Citation Count: 2
- The angiotensin (1–7) glycopeptide PNA5 improvescognition in achronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation2024OPENTitle: The angiotensin (1–7) glycopeptide PNA5 improvescognition in achronic progressive mouse model of Parkinson's disease through modulation of neuroinflammationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 381Issue #:Start Page: 114926End Page: 114926Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114926Best OA location URL: https://doi.org/10.1016/j.expneurol.2024.114926Citation Count: 2